柴蒌桃仁汤治疗稳定型心绞痛痰瘀痹阻证的临床研究被引量：6

下载PDF

导出

摘要目的:观察柴蒌桃仁汤治疗稳定型心绞痛(SAP)痰瘀痹阻证的临床疗效。方法:共入选60例SAP患者,将所有患者随机分入治疗组(中药+西药)和对照组(单用西药),每组各30例,连续用药治疗4周后,观察两组治疗前后的中医证候疗效、心绞痛程度、硝酸甘油停减疗效、心电图、血脂水平的变化。结果:治疗组中医证候疗效、心绞痛疗效显效率与对照组比较,差异均有统计学意义(P<0.05);治疗组硝酸甘油完全停用率与对照组比较差异亦有统计学意义(P<0.05);且治疗组在改善血脂指标LDL-C方面亦较对照组为优(P<0.05)。结论:柴蒌桃仁汤联合西医常规药物治疗稳定型心绞痛痰瘀痹阻证临床疗效确切,并有良好的调脂作用。

作者李淑君范金茹

机构地区岳阳市中医医院湖南中医药大学第一附属医院

出处《中医药导报》 2010年第4期19-21,共3页 Guiding Journal of Traditional Chinese Medicine and Pharmacy

关键词稳定型心绞痛柴蒌桃仁汤疏肝豁痰化瘀法临床研究

分类号 R256.22 [医药卫生—中医内科学]

引文网络
相关文献

参考文献5

1陈灏珠，戴自英，林果为，等．实用内科学[M]．12版.北京：人民卫生出版社，2005．1333—1336．
2无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量：2052
3中华人民共和国卫生部.中药新药治疗冠心病心绞痛临床研究指导原则[M].北京:人民卫生出版社,2002:41-46.
4陈可冀.心脑血管疾病研究[M].上海：上海科技出版社,1998,316?..
5范金茹.治肝之法在杂病中的运用[J].中医药学刊,2006,24(2):225-226. 被引量：9

二级参考文献48

1Lawson WE, Hui JC, Lang G. Treatment benefit in the enhanced external counterpulsation consortium. Cardiology, 2000,94 ( 1 ) :31-35.
2Ryden L, Standl E, Bartnic M, et al. Guideline on diabetes, prediabetes and cardiovascular disease:executive summary. The Task Force on Diabetes and Cardiovascular Disease of European Society of Cardiology (ESC) and of the Euopean Association for the Study of Diabetes(EASD). Eur Heart J,2007,28( 1 ) :88-136.
3Crawford MH, Bernstein SJ, Deedwania PC, et al. ACC/AHA Guidelines for Ambulatory Electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Committee to Revise the Guidelines for Ambulatory Electrocardiography). Developed in collaboration with the North American Society for Pacing and Electrophysiology.J Am Coll Cardiol,1999,34(3) :912-948.
4Campeau L. Letter: Grading of angina pectoris. Circulation 1976 :54(3) :522-523.
5O'Rourke RA, Brundage BH, Froelicher VF, et al. American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol, 2000,36(1) :326-340.
6Gibbons Pal, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-sunanary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol, 2003,41 ( 1 ) : 159-168.
7Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation, 2004,110(10) :1245-1250.
8Girman CJ, Rhodes T, Mercuri M,et al. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherescleresis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol,2004,93 ( 2 ) : 136-141.
9Kjekshus JK, Maroko PB, Sobel BE. Distribution of myocardial injury and its relation to epicardial ST-segment changes after coronary artery occlusion in the dog. Cardiovasc Res,1972,6(5) :490-499.
10Kleber AG. ST-segment elevation in the electrocardiogram: a sign of myecaniial iechemia. Cardiovasc Res, 2000,45(1) :111-118.